An investigation by South Africa's Health Products Regulatory Authority found no trace of toxins in two recalled batches of children's cough syrup made by Johnson & Johnson. No adverse events were reported. Kenvue, the current owner of the Benylin brand, affirmed the safety of the recalled batches.
The recalled batch of Benylin syrup was made by Johnson & Johnson in South Africa in May 2021, although Kenvue (KVUE.N) now owns the brand after a spin-off from J&J last year
A contaminated batch of Benylin Paediatric Syrup is no longer available in the African countries where it was sold, the World Health Organization said on Monday. Earlier this month, Nigeria recalled a batch of the children's cough and allergy medicine after tests found that it contained unacceptable levels of the toxin, diethylene glycol. Five other African countries have also pulled the product from shelves - Kenya, Rwanda, Tanzania, Zimbabwe and South Africa, where the drug was made.
A contaminated batch of
Benylin Paediatric Syrup is no longer available in the African
countries where it was sold, the World Health Organization said
on Monday. Earlier this month,.
Drug regulators in several African countries have recalled a batch of Johnson & Johnson children’s cough syrup after officials in Nigeria reported high levels of toxicity in one batch of the drug.
Officials in Kenya, Nigeria, Rwanda, South Africa, Tanzania, and Zimbabwe have recalled batch 329203 of the oral medicine, typically used to treat coughs, hay fever, and other allergic reactions in children. While the other countries have stopped trade and use of the drugs in the batch, South Africa has recalled an additional batch.
The South African Health Products Regulatory Authority (SAHPRA) said it received a report on 13 April from the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) regarding the detection of high levels of diethylene glycol in a batch of Benylin Paediatric Syrup.1 Diethylene glycol is an organic substance …